Dr. Shawl is currently the Director of Interventional Cardiology at Washington Adventist Hospital in Takoma Park, Maryland, as well as Professor and Director of Interventional Cardiovascular Medicine at George Washington University School of Medicine in Washington, D.C., USA. A true innovator in working with the high risk patient, Dr. Shawl was the first Interventional Cardiologist to use both the Eclipse Holmium Laser as well as the AngioTrax mechanical device (1999) for Percutaneous Transluminal Myocardial Revascularization in the investigational treatment of end-stage atherosclerotic heart disease (patients with no options). He did both procedures as part of research first in world at New Delhi, India. He was also first to perform mitral valvuloplasty in the Washington, DC metropolitan area in 1985. Dr. Shawl is a member of the renowned International Gruentzig Society and was recognized as one of the world's most talented interventionists in an interview for the Journal of Invasive Cardiology in April 2001 (JIC, Vol. 13, No. 4, April 2001). He was acknowledged to have performed the most interventional procedures as a single operator (over 19,000) than any other interventionist in the world.

Dr Rath is Senior Consultant, Interventional Cardiologist, Apollo Hospitals, Hydrabad, with vast experience in Tans Radial and Trans Ulnar Coronary Angioplasty.

Dr Vijay Kakkar is Director of Thrombosis Research Institute,, London. He has tremendous contribution in development of several anti thombotic molecules utilized in treatment of unstable coronary artery disease.

Professor Di Mario studied Medicine in Italy, his home country. He then moved to Thoraxcentre Rotterdam and gained professional experience and obtained his PhD degree under Prof. Patrick W. Serruys. He worked as a research and clinical director for interventional cardiology at the San Raffaele Hospital in Milan, before taking up a specialist post at Royal Brompton & Harefield NHS Trust, London. A fellow of the European Society of Cardiology, he has written numerous articles, including the one in Lancet in which he reported the experience with a new biodegradable stent. Professor Di Mario is regularly invited to speak at prestigious conferences and to share unusual cases; Professor Di Mario has broadcasted live transmissions of interventional cardiology procedures to thousands of international colleagues across Europe, Asia and the United States. Professor Di Mario has led the development of the first official European training program for interventional cardiology fellows and he is the president of the European Association of Percutaneous Cardiovascular Interventions.

Prof. Rothman is a consultant cardiologist and cardiac research and development director and director of the Heart Attack Centre at Barts and the London NHS Trust. He is also honorary senior lecturer to the Medical College of St Mary Westfield, University of London and lectures regularly in cardiology and related subjects. He travels worldwide to give lectures and demonstrations to professional audiences in cardiology and the use of cardiology devices. Prof. Rothman is a Fellow of the American College of Cardiology, a Fellow of the Royal College of Physicians and Fellow of the European College of Cardiology. His research experience includes coronary intervention, structural heart disease (device closure), prosthetic graft technology and interventional devices and intravascular ultrasound.